Literature DB >> 22669270

Quality of dying in head and neck cancer patients: the role of surgical palliation.

Jimmy Yu Wai Chan1, Victor Shing Howe To, Stanley Tien Sze Wong, William Ignace Wei.   

Abstract

To study the role of surgery for symptom palliation in patients with advanced head and neck malignancy. Between 2000 and 2011, patients with locoregionally advanced cancer in the head and neck region, who chose surgical palliation for symptom control, were studied retrospectively. During the study period, 52 patients were included. The index tumour included carcinoma of the maxilla (23.1 %), tongue (19.2 %), larynx/hypopharynx (15.4 %), post-radiation sarcoma (11.5 %), primary sarcoma (11.5 %), carcinoma of the lower alveolus (11.5 %), nasal mucosal melanoma (3.9 %) and metastatic tumour in the head and neck region (3.9 %). The major symptoms included bleeding (53.9 %), tumour pain (19.2 %), dysphagia (11.5 %), non-healing ulcerations (7.7 %), airway obstruction (5.8 %) and pathological fracture of the mandible (1.9 %). Ligation of the carotid artery was performed in 10 patients, complete resection of tumour in 35, and surgical debulking of the tumour in 7 patients. Mean survival of the patients was 5.6 months. The majority of the patients achieved satisfactory and persistent control of symptoms. One patient died from pneumonia during the hospital stay, and the rest were discharged after a mean duration of 16.4 days. In selected patients, surgery is effective in palliating symptoms which are otherwise difficult to manage. Detailed planning and good communication is the key to success in improving the quality of dying.

Entities:  

Mesh:

Year:  2012        PMID: 22669270     DOI: 10.1007/s00405-012-2059-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  17 in total

Review 1.  Care of the dying patient: the last hours or days of life.

Authors:  John Ellershaw; Chris Ward
Journal:  BMJ       Date:  2003-01-04

2.  A very good death: measuring quality of dying in end-stage renal disease.

Authors:  L M Cohen; D M Poppel; G M Cohn; G S Reiter
Journal:  J Palliat Med       Date:  2001       Impact factor: 2.947

Review 3.  Profiling early head and neck cancer.

Authors:  Keith D Hunter; E Ken Parkinson; Paul R Harrison
Journal:  Nat Rev Cancer       Date:  2005-02       Impact factor: 60.716

4.  Factors considered important at the end of life by patients, family, physicians, and other care providers.

Authors:  K E Steinhauser; N A Christakis; E C Clipp; M McNeilly; L McIntyre; J A Tulsky
Journal:  JAMA       Date:  2000-11-15       Impact factor: 56.272

5.  The last 48 hours of life.

Authors:  I Lichter; E Hunt
Journal:  J Palliat Care       Date:  1990       Impact factor: 2.250

6.  A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). The SUPPORT Principal Investigators.

Authors: 
Journal:  JAMA       Date:  1995 Nov 22-29       Impact factor: 56.272

7.  Endovascular management of carotid blowout syndrome in patients with head and neck cancers.

Authors:  Jong-Lyel Roh; Dae Chul Suh; Mi Ra Kim; Jeong Hyun Lee; Jin Woo Choi; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  Oral Oncol       Date:  2008-01-22       Impact factor: 5.337

8.  Endovascular management of impending carotid rupture in a patient with advanced head and neck cancer.

Authors:  Mark C Bates; Fadi M Shamsham
Journal:  J Endovasc Ther       Date:  2003-02       Impact factor: 3.487

9.  Problems of terminal head and neck cancer patients.

Authors:  D P Shedd; A Carl; C Shedd
Journal:  Head Neck Surg       Date:  1980 Jul-Aug

10.  Terminal cancer care and patients' preference for place of death: a prospective study.

Authors:  J Townsend; A O Frank; D Fermont; S Dyer; O Karran; A Walgrove; M Piper
Journal:  BMJ       Date:  1990-09-01
View more
  2 in total

1.  End-of-life care for head and neck cancer patients: a population-based study.

Authors:  Tzu-Lung Kuo; Ching-Heng Lin; Rong-San Jiang; Ting-Ting Yen; Chen-Chi Wang; Kai-Li Liang
Journal:  Support Care Cancer       Date:  2016-12-30       Impact factor: 3.603

2.  Therapeutic efficacy of selective intra-arterial chemoradiotherapy with docetaxel and nedaplatin for fixed bulky nodal disease in head and neck cancer of unknown primary.

Authors:  Joichi Heianna; Wataru Makino; Hitoshi Hirakawa; Shinya Agena; Hayato Tomita; Takuro Ariga; Kazuki Ishikawa; Shota Takehara; Hitoshi Maemoto; Sadayuki Murayama
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-10-10       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.